Novartis updates Phase IIIb ribociclib adjuvant breast cancer trial; four prior items holdOct 23Weekly roundup, 5 itemsarumakimigNovartisUpdated
Amneal wins REMS supplement approvals for two isotretinoin ANDAs, labeling update for valsartanOct 7Weekly roundup, 4 itemsAmneal Pharmaceuticals, LLCestradiol
Novartis updates Leqvio label; MS study recruiting, thyroid study not yet recruitingAug 21Weekly roundup, 8 itemsGIA632inclisiran